Cas no 475108-18-0 (Tivozanib)
Tivozanib structure
Product Name:Tivozanib
CAS No:475108-18-0
MF:C22H19ClN4O5
MW:454.863064050674
MDL:MFCD15146788
CID:68202
PubChem ID:9911830
Update Time:2025-04-18
Tivozanib Chemical and Physical Properties
Names and Identifiers
-
- N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea
- Tivozanib (AV-951)
- 1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)-oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea
- 1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea
- 1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea
- Av951
- AV-951
- AV951 Tivozanib
- Tivozanib
- Tivozanib AV-951
- Tivozanib(AV-951,ASP4130,KRN-951)
- AV951,AV-951
- KRN-951
- Tivozanib,AV951,AV-951
- AV 951
- KRN951
- KRN 951
- 1-(2-CHLORO-4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-3-(5-METHYLISOXAZOL-3-YL)UREA
- 172030934T
- fotivda
- Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor IV
- N-(2-C
-
- MDL： MFCD15146788
- Inchi： 1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28)
- InChI Key： SPMVMDHWKHCIDT-UHFFFAOYSA-N
- SMILES： ClC1C=C(C=CC=1NC(NC1C=C(C)ON=1)=O)OC1C=CN=C2C=C(C(=CC2=1)OC)OC
Computed Properties
- Exact Mass: 454.10400
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 7
- Heavy Atom Count: 32
- Rotatable Bond Count: 6
- Complexity: 631
- Topological Polar Surface Area: 108
Experimental Properties
- Density: 1.421
- Melting Point: 208-213°C
- Boiling Point: 550.4±50.0°C at 760 mmHg
- PSA: 107.74000
- LogP: 5.78410
Tivozanib Security Information
- Signal Word：Warning
- Hazard Statement： H315; H319; H335
- Warning Statement： P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
- Storage Condition：Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month
Tivozanib Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | T126012-100mg |
Tivozanib |
475108-18-0 | ≥98% | 100mg |
￥6344.90 | 2023-08-31 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | T126012-25mg |
Tivozanib |
475108-18-0 | ≥98% | 25mg |
￥2265.90 | 2023-08-31 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | T126012-5mg |
Tivozanib |
475108-18-0 | ≥98% | 5mg |
￥679.90 | 2023-08-31 | |
| S e l l e c k ZHONG GUO | S1207-10mM (1mL in DMSO) |
Tivozanib (AV-951) |
475108-18-0 | 99.64% | 10mM (1mL in DMSO) |
￥1963.28 | 2023-09-16 | |
| S e l l e c k ZHONG GUO | S1207-5mg |
Tivozanib (AV-951) |
475108-18-0 | 99.64% | 5mg |
￥977.17 | 2023-09-16 | |
| S e l l e c k ZHONG GUO | S1207-10mg |
Tivozanib (AV-951) |
475108-18-0 | 99.64% | 10mg |
￥1415.05 | 2023-09-16 | |
| S e l l e c k ZHONG GUO | S1207-50mg |
Tivozanib (AV-951) |
475108-18-0 | 99.64% | 50mg |
￥4648.03 | 2023-09-16 | |
| S e l l e c k ZHONG GUO | S1207-100mg |
Tivozanib (AV-951) |
475108-18-0 | 99.64% | 100mg |
￥8165.43 | 2023-09-16 | |
| S e l l e c k ZHONG GUO | S1207-200mg |
Tivozanib (AV-951) |
475108-18-0 | 99.05% | 200mg |
￥13980.33 | 2022-04-26 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R026072-10mg |
Tivozanib (AV-951),99% |
475108-18-0 | 99% | 10mg |
￥1098 | 2024-05-23 |
Tivozanib Suppliers
Amadis Chemical Company Limited
Gold Member
Audited Supplier
(CAS:475108-18-0)Tivozanib
Order Number:A24970
Stock Status:in Stock
Quantity:1g/250mg/100mg
Purity:99%
Pricing Information Last Updated:Friday, 30 August 2024 04:17
Price ($):839.0/307.0/181.0
Email:[email protected]
Tiancheng Chemical (Jiangsu) Co., Ltd
Gold Member
Audited Supplier
(CAS:475108-18-0)替沃扎尼
Order Number:LE26881537
Stock Status:in Stock
Quantity:25KG,200KG,1000KG
Purity:99%
Pricing Information Last Updated:Friday, 20 June 2025 12:59
Price ($):discuss personally
Email:[email protected]
Tivozanib Related Literature
-
Fang Qiao,Yong Yin,Yu-Ning Shen,She-Feng Wang,Shao Sha,Xun Wu,Ai-Min Lu,Chen Xu,Wei-Ming Zhang,Hai-Liang Zhu RSC Adv. 2015 5 19914
-
Jian Sun,Dong-Dong Li,Jing-Ran Li,Fei Fang,Qian-Ru Du,Yong Qian,Hai-Liang Zhu Org. Biomol. Chem. 2013 11 7676
-
Viviana Cuartas,Alberto Aragón-Muriel,Yamil Liscano,Dorian Polo-Cerón,Maria del Pilar Crespo-Ortiz,Jairo Quiroga,Rodrigo Abonia,Braulio Insuasty RSC Adv. 2021 11 23310
-
Anna V. Leopold,Vladislav V. Verkhusha Chem. Sci. 2020 11 10019
-
Meiyue Song,Yan Yan,Zhenran Jiang Mol. BioSyst. 2014 10 2907
Related Categories
- Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Diarylethers
- Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Diarylethers
- Other Chemical additives Functional Additives
- Pharmaceutical and Biochemical Products Medical Target Class
475108-18-0 (Tivozanib) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)
